<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fan L</submitter><funding>Chinese National Natural Science Foundation</funding><pagination>1895</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12528569</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Head and Neck Squamous Cell Carcinoma (HNSCC) is an aggressive malignancy with poor prognosis and low five-year survival rates. Ferroptosis, an iron-dependent form of cell death, has emerged as a potential factor in cancer therapy. This study aimed to identify differentially expressed genes (DEGs) associated with HNSCC, ferroptosis, and radiotherapy, and to develop a diagnostic model to establish novel biomarkers, early diagnosis and individualized therapy.&lt;h4>Methods&lt;/h4>We analyzed TCGA-HNSCC, GSE6631, and GSE107591 datasets to identify Ferroptosis- and Radiotherapy-Related Differentially Expressed Genes (F&amp;RRDEGs).Ferroptosis &amp; radiotherapy scores were calculated, followed by immune infiltration and immunotherapy analyses. A Cox prognostic model was evaluated using no</pubmed_abstract><journal>Discover oncology</journal><pubmed_title>Ferroptosis and radiotherapy-related genes in head and neck squamous cell carcinoma: diagnostic and prognostic significance.</pubmed_title><pmcid>PMC12528569</pmcid><funding_grant_id>82071168</funding_grant_id><pubmed_authors>Shi L</pubmed_authors><pubmed_authors>Mu Y</pubmed_authors><pubmed_authors>Fan L</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ferroptosis and radiotherapy-related genes in head and neck squamous cell carcinoma: diagnostic and prognostic significance.</name><description>&lt;h4>Background&lt;/h4>Head and Neck Squamous Cell Carcinoma (HNSCC) is an aggressive malignancy with poor prognosis and low five-year survival rates. Ferroptosis, an iron-dependent form of cell death, has emerged as a potential factor in cancer therapy. This study aimed to identify differentially expressed genes (DEGs) associated with HNSCC, ferroptosis, and radiotherapy, and to develop a diagnostic model to establish novel biomarkers, early diagnosis and individualized therapy.&lt;h4>Methods&lt;/h4>We analyzed TCGA-HNSCC, GSE6631, and GSE107591 datasets to identify Ferroptosis- and Radiotherapy-Related Differentially Expressed Genes (F&amp;RRDEGs).Ferroptosis &amp; radiotherapy scores were calculated, followed by immune infiltration and immunotherapy analyses. A Cox prognostic model was evaluated using no</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-07-15T14:37:20.39Z</modification><creation>2026-07-06T03:08:43.48Z</creation></dates><accession>S-EPMC12528569</accession><cross_references><pubmed>41091342</pubmed><doi>10.1007/s12672-025-03713-7</doi></cross_references></HashMap>